CV
MRK icon

Counterweight Ventures’s Merck MRK Stock Holding History

Counterweight Ventures’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.09M Sell
24,081
-1,005
-4% -$118K 1.54% 25
2026
Q1 		$3.02M Sell
25,086
-4,800
-16% -$554K 1.69% 22
2025
Q4 		$3.15M Sell
29,886
-176
-0.6% -$16.5K 1.76% 19
2025
Q3 		$2.52M Buy
30,062
+6,049
+25% +$498K 1.48% 24
2025
Q2 		$1.9M Buy
24,013
+839
+4% +$66.7K 1.24% 30
2025
Q1 		$2.08M Buy
23,174
+716
+3% +$66.8K 1.49% 28
2024
Q4 		$2.23M Buy
22,458
+351
+2% +$36.2K 1.58% 24
2024
Q3 		$2.51M Buy
22,107
+1,558
+8% +$185K 1.78% 24
2024
Q2 		$2.54M Buy
20,549
+251
+1% +$32.3K 1.92% 21
2024
Q1 		$2.68M Sell
20,298
-510
-2% -$62.9K 2.16% 20
2023
Q4 		$2.27M Buy
+20,808
New +$2.16M 2.06% 20

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Counterweight Ventures's MRK Position: Q2 2026 in Review

Counterweight Ventures reduced its Merck (MRK) stake by 4% in Q2 2026, selling an estimated $118K and leaving 24,081 shares worth $3.09M. The position accounts for 1.54% of the portfolio, ranked #25.

Counterweight Ventures first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.15M in Q4 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Counterweight Ventures held 24,081 shares of Merck worth $3.09M as of Q2 2026.
  • Counterweight Ventures sold 1,005 Merck shares in Q2 2026, an estimated $118K.
  • Merck made up 1.54% of Counterweight Ventures's portfolio in Q2 2026, its #25 holding.
  • Counterweight Ventures first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Counterweight Ventures's Merck position peaked at $3.15M in Q4 2025.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Counterweight Ventures's 13F filing for Q2 2026, filed 23 Jul 2026.